Journal articlePreclinical
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse
American journal of physiology. Endocrinology and metabolism, 2006 Dec. Alba M, Fintini D, Sagazio A and 4 others.
Study type
Journal article
Subjects
Animal / preclinical (no Humans MeSH term)
Journal
American journal of physiology. Endocrinology and metabolism
Published
2006 Dec
PubMed
Where PepCue cites this
This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.
Indexed under
MeSH terms assigned by the National Library of Medicine.
AgingAnimalsBlotting, NorthernBody CompositionBody WeightBone DevelopmentCell ProliferationFemurGrowthGrowth HormoneGrowth Hormone-Releasing HormoneImmunohistochemistry
Other papers on CJC-1295 DAC
Randomized controlled trial · 2006
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Clinical trial · 2006Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page